Literature DB >> 15673262

Mercuric triflate-catalyzed tandem cyclization leading to polycarbocycles.

Hiroshi Imagawa1, Tomoaki Iyenaga, Mugio Nishizawa.   

Abstract

[reaction: see text] We developed Hg(OTf)2-catalyzed cyclization of (E)-1,3-dimethoxy-5-(4-methyl-3-nonen-7-ynyl)benzene leading to the formation of (4aS,10aS)-3,4,4a,9,10,10a-hexahydro-5,7-dimethoxy-1,4a-dimethylphenanthrene in 98% yield with up to 100 catalytic turnovers. This is the first mercuric salt-catalyzed biomimetic tandem cyclization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673262     DOI: 10.1021/ol047472t

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  6 in total

1.  Toward palau'amine: Hg(OTf)2-catalyzed synthesis of the cyclopentane core.

Authors:  Kosuke Namba; Yukari Kaihara; Hirofumi Yamamoto; Hiroshi Imagawa; Keiji Tanino; Robert M Williams; Mugio Nishizawa
Journal:  Chemistry       Date:  2009-07-06       Impact factor: 5.236

2.  Gold(I)-catalyzed enantioselective polycyclization reactions.

Authors:  Steven G Sethofer; Timo Mayer; F Dean Toste
Journal:  J Am Chem Soc       Date:  2010-06-23       Impact factor: 15.419

3.  Catalytic platinum-initiated cation-olefin reactions with alkene terminating groups.

Authors:  Joseph G Sokol; Nikki A Cochrane; Jennifer J Becker; Michel R Gagné
Journal:  Chem Commun (Camb)       Date:  2013-04-26       Impact factor: 6.222

4.  Gold(I)-catalyzed cascade cyclization of allenyl epoxides.

Authors:  Michael A Tarselli; J Lucas Zuccarello; Stephen J Lee; Michel R Gagné
Journal:  Org Lett       Date:  2009-08-06       Impact factor: 6.005

5.  Platinum(II) Enyne Cycloisomerization Catalysis: Intermediates and Resting States.

Authors:  D Luke Nelsen; Michel R Gagné
Journal:  Organometallics       Date:  2009-02-23       Impact factor: 3.876

6.  Diastereoselective Pt catalyzed cycloisomerization of polyenes to polycycles.

Authors:  Michael J Geier; Michel R Gagné
Journal:  J Am Chem Soc       Date:  2014-02-13       Impact factor: 15.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.